Themis Medicare Limited ( (IN:THEMISMED) ) just unveiled an announcement.
Themis Medicare Limited has announced the receipt of a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending March 31, 2025. This certificate, provided by MUFG Intime India Pvt. Ltd., confirms that the securities received for dematerialization have been processed and listed on the stock exchanges, ensuring compliance with regulatory requirements. This announcement reinforces the company’s commitment to maintaining regulatory compliance, which is crucial for its operations and stakeholder trust.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is based in India and engages in the production of a wide range of medicinal products, catering to various therapeutic areas.
YTD Price Performance: -53.44%
Average Trading Volume: 14,600
Current Market Cap: 11.33B INR
For a thorough assessment of THEMISMED stock, go to TipRanks’ Stock Analysis page.